Tempus is a healthcare technology company that operates five high-throughput laboratories offering AI-powered molecular diagnostic tests, including oncology profiling, hereditary disease screening, and pharmacogenomic testing, while monetizing a proprietary dataset of de-identified clinical, genomic, and imaging data across millions of patient records. The company generates revenue primarily through insurance reimbursement and patient billing for diagnostic tests, and through multi-year licensing agreements with pharmaceutical companies that use Tempus's data and analytics platform to accelerate drug discovery and clinical trial recruitment. By connecting diagnostic test results to patients' unique clinical data and building network effects across healthcare providers and life sciences companies, Tempus aims to improve diagnostic accuracy and enable personalized medicine at scale.